Literature DB >> 10973484

IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production.

H Ochi1, N H De Jesus, F H Hsieh, K F Austen, J A Boyce.   

Abstract

Mast cells (MC) are stem cell factor-dependent tissue-based hematopoietic cells with substantial functional heterogeneity. Cord blood-derived human MC (hMC) express functional receptors for IL-5, and IL-5 mediates stem cell factor-dependent comitogenesis of hMC in vitro. Although IL-5 is not required for normal hMC development, we considered that it might prime hMC for their high-affinity Fc receptor for IgE (FcvarepsilonRI)-dependent generation of cytokines, as previously demonstrated for IL-4. Compared with hMC maintained in stem cell factor alone, hMC primed with IL-5 expressed 2- to 4-fold higher steady-state levels of TNF-alpha, IL-5, IL-13, macrophage inflammatory protein 1alpha, and granulocyte-macrophage colony-stimulating factor transcripts 2 h after FcvarepsilonRI crosslinking and secreted 2- to 5-fold greater quantities of the corresponding cytokines, except IL-13, at 6 h. Unlike IL-4, IL-5 priming did not enhance FcvarepsilonRI-dependent histamine release. Thus, IL-5 augments cytokine production by hMC by a mechanism distinct from that of IL-4 and with a different resultant profile of cytokine production. These observations suggest a potentially autocrine effect of IL-5 on hMC for amplification of allergic immune responses, in addition to its recognized paracrine effects on eosinophils, and implicate both IL-4 and IL-5 in the modulation of the hMC phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973484      PMCID: PMC27055          DOI: 10.1073/pnas.180318697

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor.

Authors:  R A Briddell; V C Broudy; E Bruno; J E Brandt; E F Srour; R Hoffman
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

2.  Decreased production of mast cells in S1/S1d anemic mice.

Authors:  Y Kitamura; S Go
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

3.  IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein.

Authors:  E U Sarmiento; B R Espiritu; G J Gleich; L L Thomas
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

4.  IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells.

Authors:  Y Okayama; C Petit-Frére; O Kassel; A Semper; D Quint; M J Tunon-de-Lara; P Bradding; S T Holgate; M K Church
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

5.  Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation.

Authors:  Y Kitamura; S Go; K Hatanaka
Journal:  Blood       Date:  1978-08       Impact factor: 22.113

6.  Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells.

Authors:  H Saito; M Ebisawa; H Tachimoto; M Shichijo; K Fukagawa; K Matsumoto; Y Iikura; T Awaji; G Tsujimoto; M Yanagida; H Uzumaki; G Takahashi; K Tsuji; T Nakahata
Journal:  J Immunol       Date:  1996-07-01       Impact factor: 5.422

7.  Heterogeneity of human mast cells based on cytokine content.

Authors:  P Bradding; Y Okayama; P H Howarth; M K Church; S T Holgate
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

8.  Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population.

Authors:  M Rottem; T Okada; J P Goff; D D Metcalfe
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

9.  Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate.

Authors:  J A Boyce; D Friend; R Matsumoto; K F Austen; W F Owen
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

10.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcεRI.

Authors:  Tanya M Laidlaw; John W Steinke; Adrienne M Tiñana; Chunli Feng; Wei Xing; Bing K Lam; Sailaja Paruchuri; Joshua A Boyce; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2011-02-01       Impact factor: 10.793

Review 3.  Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsia.

Authors:  Craig A Friesen; Jennifer V Schurman; Jennifer M Colombo; Susan M Abdel-Rahman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

4.  CD4+ T cells enhance the unloaded shortening velocity of airway smooth muscle by altering the contractile protein expression.

Authors:  Oleg S Matusovsky; Emily M Nakada; Linda Kachmar; Elizabeth D Fixman; Anne-Marie Lauzon
Journal:  J Physiol       Date:  2014-03-31       Impact factor: 5.182

Review 5.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 6.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

7.  IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis.

Authors:  Todd M Wilson; Irina Maric; Juhi Shukla; Margaret Brown; Carlo Santos; Olga Simakova; Paneez Khoury; Michael P Fay; Alexander Kozhich; Roland Kolbeck; Dean D Metcalfe; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2011-07-16       Impact factor: 10.793

8.  Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.

Authors:  Iris M Otani; Arjun A Anilkumar; Robert O Newbury; Monica Bhagat; Lisa Y Beppu; Ranjan Dohil; David H Broide; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2013-04-25       Impact factor: 10.793

9.  IL-33 is produced by mast cells and regulates IgE-dependent inflammation.

Authors:  Chia-Lin Hsu; Colleen V Neilsen; Paul J Bryce
Journal:  PLoS One       Date:  2010-08-03       Impact factor: 3.240

10.  Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions.

Authors:  Carole A Oskeritzian; Sergio E Alvarez; Nitai C Hait; Megan M Price; Sheldon Milstien; Sarah Spiegel
Journal:  Blood       Date:  2008-01-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.